These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36648839)

  • 21. Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis.
    Saito M; McGready R; Tinto H; Rouamba T; Mosha D; Rulisa S; Kariuki S; Desai M; Manyando C; Njunju EM; Sevene E; Vala A; Augusto O; Clerk C; Were E; Mrema S; Kisinza W; Byamugisha J; Kagawa M; Singlovic J; Yore M; van Eijk AM; Mehta U; Stergachis A; Hill J; Stepniewska K; Gomes M; Guérin PJ; Nosten F; Ter Kuile FO; Dellicour S
    Lancet; 2023 Jan; 401(10371):118-130. PubMed ID: 36442488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artemisinin-based combination therapy for treating uncomplicated malaria.
    Sinclair D; Zani B; Donegan S; Olliaro P; Garner P
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007483. PubMed ID: 19588433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artemisinin-based combination therapy: knowledge and perceptions of patent medicine dealers in Owerri Metropolis, Imo State, Nigeria and implications for compliance with current malaria treatment protocol.
    Chukwuocha UM; Nwakwuo GC; Mmerole I
    J Community Health; 2013 Aug; 38(4):759-65. PubMed ID: 23539134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to antimalarial drug policy among doctors in Delta State, Nigeria: implications for malaria control.
    Obiebi IP
    Ghana Med J; 2019 Jun; 53(2):109-116. PubMed ID: 31481806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-Drug Interactions of Artemisinin-Based Combination Therapies in Malaria Treatment: A Narrative Review of the Literature.
    Hernandez Maldonado J; Grundmann O
    J Clin Pharmacol; 2022 Oct; 62(10):1197-1205. PubMed ID: 35543380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial.
    Tripura R; von Seidlein L; Sovannaroth S; Peto TJ; Callery JJ; Sokha M; Ean M; Heng C; Conradis-Jansen F; Madmanee W; Peerawaranun P; Waithira N; Khonputsa P; Jongdeepaisal M; Pongsoipetch K; Chotthanawathit P; Soviet U; Pell C; Duanguppama J; Rekol H; Tarning J; Imwong M; Mukaka M; White NJ; Dondorp AM; Maude RJ
    Lancet Infect Dis; 2023 Jan; 23(1):81-90. PubMed ID: 36174595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress toward elimination of malaria in Nigeria: uptake of artemisinin-based combination therapies for the treatment of malaria in households in Benin City.
    Akoria OA; Arhuidese IJ
    Ann Afr Med; 2014; 13(3):104-13. PubMed ID: 24923369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substandard artemisinin-based antimalarial medicines in licensed retail pharmaceutical outlets in Ghana.
    El-Duah M; Ofori-Kwakye K
    J Vector Borne Dis; 2012 Sep; 49(3):131-9. PubMed ID: 23135006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Misuse of Artemisinin Combination Therapies by Clients of Medicine Retailers Suspected to Have Malaria Without Prior Parasitological Confirmation in Nigeria.
    Nwokolo E; Ujuju C; Anyanti J; Isiguzo C; Udoye I; BongosIkwue E; Ezire O; Raji M; Oyibo WA
    Int J Health Policy Manag; 2018 Jun; 7(6):542-548. PubMed ID: 29935131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate.
    Gendrot M; Duflot I; Boxberger M; Delandre O; Jardot P; Le Bideau M; Andreani J; Fonta I; Mosnier J; Rolland C; Hutter S; La Scola B; Pradines B
    Int J Infect Dis; 2020 Oct; 99():437-440. PubMed ID: 32805422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimum population-level use of artemisinin combination therapies: a modelling study.
    Nguyen TD; Olliaro P; Dondorp AM; Baird JK; Lam HM; Farrar J; Thwaites GE; White NJ; Boni MF
    Lancet Glob Health; 2015 Dec; 3(12):e758-66. PubMed ID: 26545449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of artemether-lumefantrine for the treatment of uncomplicated
    Ghimire P; Rijal KR; Kafle C; Karki BS; Singh N; Ortega L; Thakur GD; Adhikari B
    Trop Dis Travel Med Vaccines; 2018; 4():9. PubMed ID: 30123520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.
    Hamaluba M; van der Pluijm RW; Weya J; Njuguna P; Ngama M; Kalume P; Mwambingu G; Ngetsa C; Wambua J; Boga M; Mturi N; Lal AA; Khuroo A; Taylor WRJ; Gonçalves S; Miotto O; Dhorda M; Mutinda B; Mukaka M; Waithira N; Hoglund RM; Imwong M; Tarning J; Day NPJ; White NJ; Bejon P; Dondorp AM
    Lancet Infect Dis; 2021 Oct; 21(10):1395-1406. PubMed ID: 34111412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subsidizing artemisinin-based combination therapies: a preliminary investigation of the Affordable Medicines Facility - malaria.
    Bate R; Hess K; Tren R; Mooney L; Cudjoe F; Ayodele T; Attaran A
    Res Rep Trop Med; 2012; 3():63-68. PubMed ID: 30890868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs.
    Wakoli DM; Ondigo BN; Ochora DO; Amwoma JG; Okore W; Mwakio EW; Chemwor G; Juma J; Okoth R; Okudo C; Yeda R; Opot BH; Cheruiyot AC; Juma D; Roth A; Ogutu BR; Boudreaux D; Andagalu B; Akala HM
    BMC Med; 2022 Nov; 20(1):448. PubMed ID: 36397090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites.
    Ajayi IO; Browne EN; Garshong B; Bateganya F; Yusuf B; Agyei-Baffour P; Doamekpor L; Balyeku A; Munguti K; Cousens S; Pagnoni F
    Malar J; 2008 Jan; 7():6. PubMed ID: 18182114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
    Gogtay N; Kannan S; Thatte UM; Olliaro PL; Sinclair D
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008492. PubMed ID: 24163021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa.
    Ajayi IO; Browne EN; Bateganya F; Yar D; Happi C; Falade CO; Gbotosho GO; Yusuf B; Boateng S; Mugittu K; Cousens S; Nanyunja M; Pagnoni F
    Malar J; 2008 Sep; 7():190. PubMed ID: 18822170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria.
    Bassat Q
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1325. PubMed ID: 22216359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial.
    Laman M; Moore BR; Benjamin JM; Yadi G; Bona C; Warrel J; Kattenberg JH; Koleala T; Manning L; Kasian B; Robinson LJ; Sambale N; Lorry L; Karl S; Davis WA; Rosanas-Urgell A; Mueller I; Siba PM; Betuela I; Davis TM
    PLoS Med; 2014 Dec; 11(12):e1001773. PubMed ID: 25549086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.